- $22.08m
- $20.47m
- 58
- 12
- 75
- 46
Annual income statement for Newhydrogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.63 | -40.7 | 12.1 | 3.18 | 1.81 |
| Operating Profit | -0.63 | 40.7 | -12.1 | -3.18 | -1.81 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -141 | 10.2 | -12.1 | -3.18 | -1.81 |
| Net Income After Taxes | -141 | 10.2 | -12.1 | -3.18 | -1.81 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -141 | 10.2 | -12.1 | -3.18 | -1.81 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -141 | 10.2 | -12.1 | -3.18 | -1.81 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.5 | -0.074 | -0.017 | -0.005 | -0.003 |